Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 231.15M | 49.03%169.24M | 320.72%643.64M | 575.89%234.01M | 584.02%113.56M | 128.13%152.99M | 137.89%50.33M | 266.89%51.43M | 109.85%34.62M | 7.90%16.6M |
| Cost of revenue | 132.37M | 169.42%113.05M | 196.49%395.94M | 375.79%157.87M | 66.82%41.96M | 42.23%133.54M | 110.66%43.09M | -12.48%32.12M | 63.48%33.18M | 53.03%25.15M |
| Gross profit | 98.79M | -21.52%56.19M | 1,173.86%247.7M | 5,176.99%76.15M | 937.35%71.6M | 172.48%19.45M | 931.34%7.24M | 185.14%19.31M | 138.00%1.44M | -714.38%-8.55M |
| Operating expense | 1.24B | -48.53%1.31B | -21.94%9.36B | -7.17%2.71B | -15.83%2.55B | -26.42%11.99B | -28.36%2.77B | -0.97%3.28B | -47.71%2.92B | -14.53%3.03B |
| Selling and administrative expenses | --421.74M | -66.91%521.72M | -4.13%5.57B | 7.63%1.43B | 8.86%1.58B | 9.89%5.81B | 3.05%1.43B | 14.56%1.6B | 8.48%1.33B | 13.60%1.45B |
| -General and administrative expense | --421.74M | -66.91%521.72M | -4.13%5.57B | 7.63%1.43B | 8.86%1.58B | 9.89%5.81B | 3.05%1.43B | 14.56%1.6B | 8.48%1.33B | 13.60%1.45B |
| Research and development costs | --819.18M | -18.69%789.92M | -38.71%3.78B | -19.60%1.27B | -38.48%971.54M | -43.88%6.17B | -46.04%1.33B | -12.32%1.68B | -63.56%1.58B | -30.35%1.58B |
| Operating profit | -1.14B | 49.31%-1.26B | 23.88%-9.11B | 9.73%-2.63B | 18.43%-2.48B | 26.66%-11.97B | 28.54%-2.76B | 2.22%-3.26B | 47.77%-2.92B | 14.31%-3.04B |
| Net non-operating interest income (expenses) | -5.35M | -242.23%-10.71M | -350.11%-53.13M | -671.99%-24.77M | 29.34%-3.13M | 48.94%-11.8M | 90.14%-1.74M | -50.48%-9.97M | 6,176.81%4.33M | -497.75%-4.43M |
| Non-operating interest income | --4.77M | -40.25%1.07M | -47.14%4.45M | -89.95%663K | 66.42%1.79M | 359.73%8.41M | -14.54%241K | 54.66%498K | 5,737.17%6.6M | -3.14%1.08M |
| Total other finance cost | --10.12M | 139.27%11.78M | 184.80%57.58M | 1,023.00%25.44M | -10.59%4.92M | -18.97%20.22M | -88.95%1.98M | 50.68%10.46M | --2.27M | --5.51M |
| Net investment income | 438.28M | -97.04%27.32M | 113.61%1.59B | 0.55%991.62M | 792.36%924.52M | -43.65%745.05M | -17.84%-817.15M | -10.17%472.43M | 1.34%986.17M | -79.94%103.6M |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | -9.08M | 55.36%-333K | 99.85%-1.33M | -1.02M | -113.83%-746K | -13,181.56%-910.32M | -916.64M | 114.93%923K | 0 | 901.49%5.39M |
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | 0 | 0 | -2,129.37%-20.11B | 16.37M | -243.99M | -793.55%-901.86M | -23,403.85%-901.86M | 0 | 0 | 0 |
| Less:Restructuring and mergern&acquisition | --0 | --0 | -93.00%63.35M | ---- | ---- | --904.96M | ---- | ---- | ---- | ---- |
| Less:Other special charges | ---- | ---- | -100.00%-6.19M | ---247.09M | --243.99M | 20.00%-3.1M | ---- | ---- | ---- | ---- |
| Less:Write off | ---- | ---- | --20.05B | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
| Other non-operating income (expenses) | 984K | -94.10%1.71M | -99.38%34.56M | -95.21%2.17M | -12.94%28.92M | 1,264.57%5.58B | 10,242.21%2.65B | 1,586.33%2.85B | -63.06%45.21M | -63.75%33.22M |
| Income before tax | -717.3M | 30.13%-1.24B | -269.99%-27.64B | 12.37%-1.65B | 38.89%-1.77B | 49.23%-7.47B | 39.49%-2.75B | 102.01%55.46M | 58.10%-1.88B | 1.24%-2.9B |
| Income tax | 5.45M | -80.37%10.39M | 1,535.55%485.32M | -24.54%29.52M | 301.97%52.94M | -1,421.47%-33.81M | -372.20%-109.74M | 52.87%23.65M | 1,742.63%39.12M | 284.30%13.17M |
| Net income | -722.75M | 31.59%-1.25B | -278.20%-28.13B | 12.61%-1.68B | 37.35%-1.82B | 49.45%-7.44B | 41.61%-2.64B | 101.15%31.81M | 57.25%-1.92B | 0.91%-2.91B |
| Net income continuous operations | ---722.75M | 31.59%-1.25B | -278.20%-28.13B | 12.61%-1.68B | 37.35%-1.82B | 49.45%-7.44B | 41.61%-2.64B | 101.15%31.81M | 57.25%-1.92B | 0.91%-2.91B |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | -722.75M | 31.59%-1.25B | -278.20%-28.13B | 12.61%-1.68B | 37.35%-1.82B | 49.45%-7.44B | 41.61%-2.64B | 101.15%31.81M | 57.25%-1.92B | 0.91%-2.91B |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -722.75M | 31.59%-1.25B | -278.20%-28.13B | 12.61%-1.68B | 37.35%-1.82B | 49.45%-7.44B | 41.61%-2.64B | 101.15%31.81M | 57.25%-1.92B | 0.91%-2.91B |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -1.56 | 56.35%-3.99 | -204.22%-119.53 | 26.72%-7.46 | 42.55%-9.14 | 58.33%-39.29 | 50.88%-13.6 | 102.21%0.4 | 65.27%-10.18 | 17.14%-15.91 |
| Diluted earnings per share | -1.872 | 56.35%-3.99 | -204.22%-119.53 | 27.20%-7.46 | 42.55%-9.14 | 58.33%-39.29 | 50.88%-13.6 | 100.91%0.1641 | 65.05%-10.2467 | 17.14%-15.91 |
| Dividend per share | ||||||||||
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |